rs398092530
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_025074.7(FRAS1):c.3151+14_3151+15dupTG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.361 in 1,561,108 control chromosomes in the GnomAD database, including 103,737 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.38 ( 11138 hom., cov: 0)
Exomes 𝑓: 0.36 ( 92599 hom. )
Consequence
FRAS1
NM_025074.7 intron
NM_025074.7 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.47
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 4-78374264-C-CTG is Benign according to our data. Variant chr4-78374264-C-CTG is described in ClinVar as [Benign]. Clinvar id is 261806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAS1 | ENST00000512123.4 | c.3151+13_3151+14insTG | intron_variant | Intron 25 of 73 | 5 | NM_025074.7 | ENSP00000422834.2 | |||
FRAS1 | ENST00000325942.11 | c.3151+13_3151+14insTG | intron_variant | Intron 25 of 41 | 1 | ENSP00000326330.6 | ||||
FRAS1 | ENST00000682513.1 | c.3151+13_3151+14insTG | intron_variant | Intron 25 of 63 | ENSP00000508201.1 | |||||
FRAS1 | ENST00000684159.1 | c.3151+13_3151+14insTG | intron_variant | Intron 25 of 44 | ENSP00000506875.1 |
Frequencies
GnomAD3 genomes AF: 0.379 AC: 57478AN: 151822Hom.: 11129 Cov.: 0
GnomAD3 genomes
AF:
AC:
57478
AN:
151822
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.337 AC: 82353AN: 244358Hom.: 14520 AF XY: 0.331 AC XY: 43873AN XY: 132578
GnomAD3 exomes
AF:
AC:
82353
AN:
244358
Hom.:
AF XY:
AC XY:
43873
AN XY:
132578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.359 AC: 505254AN: 1409168Hom.: 92599 Cov.: 30 AF XY: 0.354 AC XY: 245645AN XY: 694690
GnomAD4 exome
AF:
AC:
505254
AN:
1409168
Hom.:
Cov.:
30
AF XY:
AC XY:
245645
AN XY:
694690
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.379 AC: 57529AN: 151940Hom.: 11138 Cov.: 0 AF XY: 0.373 AC XY: 27730AN XY: 74294
GnomAD4 genome
AF:
AC:
57529
AN:
151940
Hom.:
Cov.:
0
AF XY:
AC XY:
27730
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1010
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Fraser syndrome 1 Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at